Physician profile
Hani Sbitany
NPI 1588779870
$510,113.16
in general payments reported to CMS, 2019-2025
13 companies · $48K in 2025
The $48K reported for 2025 was more than what 98% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178K · 2020: $37K · 2021: $57K · 2022: $49K · 2023: $52K · 2024: $89K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $140K · Consulting Fee: $37K · Travel and Lodging: $9,164 · Food and Beverage: $3,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $139,672.00 |
| Consulting Fee | $37,213.00 |
| Travel and Lodging | $9,164.20 |
| Food and Beverage | $3,099.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $304,693.86 | 2019-2022 | |
| Abbvie INC. | $187,270.39 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Revolve |
| Osiris Therapeutics INC. | $6,447.70 | 2019 | |
| Smith+Nephew, INC. | $3,778.79 | 2019 | |
| Convatec INC. | $3,708.35 | 2019-2025 | |
| Davol INC. | $1,560.84 | 2019-2025 | Phasix Mesh |
| Rti Surgical, INC | $1,500.00 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $446.33 | 2019-2022 | |
| Medline Industries LP | $286.94 | 2019 | |
| Kerecis Limited | $181.12 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Sientra, INC. | $168.06 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $57.63 | 2025 | |
| Kci USA, INC. | $13.15 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hani Sbitany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.